-
Inside the manufacturing area in the J 6 unit at Gulf Pharmaceutical Industries in Ras Al Khaimah. Pawan Singh / The National -
Packing of the bottles in the J6 unit at Gulf Pharmaceutical Industries in Ras Al Khaimah. Pawan Singh / The National -
Cartons of medicine in the packaging area in the J6 unit at Gulf Pharmaceutical Industries in Ras Al Khaimah. In the first half of this year, Julphar’s sales grew to Dh696.4 million, up 10.5 per cent year-on-year. Pawan Singh / The National -
A machine produces capsule medicine in the J1 unit at Gulf Pharmaceutical Industries in Ras Al Khaimah. The company is now focusing on chronic diseases as well as women’s health products. Pawan Singh / The National -
A worker checks the tablets in the sorting room. Pawan Singh / The National -
As of 2011, Saudi Arabia was the largest market for Julphar, which has a market cap of Dh2.6 billion today, followed by the UAE. Pawan Singh / The National -
The company has 11 manufacturing facilities in Ras Al Khaimah and one in Ethiopia, which opened in February. Pawan Singh / The National -
Bottles are packed by a worker. In September last year, Julphar opened its 11th insulin manufacturing plant in Ras Al Khaimah with a capacity of 1,500kg of insulin per year, or 45 million vials. Pawan Singh / The National -
Workers change before entering into the Final Purification of Insulin area. Pawan Singh / The National -
An inside view of the Final Purification of Insulin area. Pawan Singh / The National -
Despite expanding its facilities in the UAE, insulin production will still be based in its home emirate of Ras Al Khaimah. Pawan Singh / The National
In pictures: Julphar pharmaceuticals
Most popular today
